Abstract
Pharmacist-led smoking cessation programs have emerged as effective interventions in addressing the global tobacco epidemic, leveraging the accessibility and expertise of pharmacists to provide tailored behavioral counseling, pharmacological support, and follow-up care. This review examines the effectiveness of these programs, highlighting their ability to achieve higher quit rates, improved patient satisfaction, and cost-effectiveness compared to traditional methods. Various implementation models, including those in community pharmacies, hospital settings, and telehealth platforms, are explored, along with the challenges of scaling these interventions, such as limited awareness, training gaps, and inadequate reimbursement. Future directions emphasize innovations in digital tools, personalized medicine, artificial intelligence, and policy and funding support to enhance program reach and sustainability. Recommendations are provided for pharmacists, healthcare systems, and policymakers to address barriers, expand access, and foster collaboration, ultimately integrating pharmacist-led smoking cessation into mainstream healthcare as a critical strategy for tobacco control.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call